ID   ARY2_HUMAN              Reviewed;         290 AA.
AC   P11245; O43637; O60654; O60655; Q13146; Q16697; Q2MLE4; Q2MLF5;
AC   Q2MLG8; Q2MLJ6; Q2MLK4; Q2MLK6; Q2MLN7; Q6LET4; Q86XS0; Q86XS1;
AC   Q96KY8; Q96T64; Q96T65; Q9H220;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   15-MAR-2017, entry version 166.
DE   RecName: Full=Arylamine N-acetyltransferase 2;
DE            EC=2.3.1.5;
DE   AltName: Full=Arylamide acetylase 2;
DE   AltName: Full=N-acetyltransferase type 2;
DE            Short=NAT-2;
DE   AltName: Full=Polymorphic arylamine N-acetyltransferase;
DE            Short=PNAT;
GN   Name=NAT2; Synonyms=AAC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2734109; DOI=10.1093/nar/17.10.3978;
RA   Grant D.M., Blum M., Demierre A., Meyer U.A.;
RT   "Nucleotide sequence of an intronless gene for a human arylamine N-
RT   acetyltransferase related to polymorphic drug acetylation.";
RL   Nucleic Acids Res. 17:3978-3978(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2340091; DOI=10.1089/dna.1990.9.193;
RA   Blum M., Grant D.M., McBride W., Heim M., Meyer U.A.;
RT   "Human arylamine N-acetyltransferase genes: isolation, chromosomal
RT   localization, and functional expression.";
RL   DNA Cell Biol. 9:193-203(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLU-286.
RC   TISSUE=Liver;
RX   PubMed=1968463;
RA   Ohsako S., Deguchi T.;
RT   "Cloning and expression of cDNAs for polymorphic and monomorphic
RT   arylamine N-acetyltransferases from human liver.";
RL   J. Biol. Chem. 265:4630-4634(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE NAT2*6D), AND VARIANTS
RP   GLN-197 AND GLU-286.
RC   TISSUE=Liver;
RX   PubMed=1381364;
RA   Deguchi T.;
RT   "Sequences and expression of alleles of polymorphic arylamine N-
RT   acetyltransferase of human liver.";
RL   J. Biol. Chem. 267:18140-18147(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES NAT2*5C AND NAT2*14), AND
RP   VARIANTS GLN-64; THR-114 AND ARG-268.
RX   PubMed=7915226;
RA   Ferguson R.J., Doll M.A., Rustan T.D., Gray K., Hein D.W.;
RT   "Cloning, expression, and functional characterization of two mutant
RT   (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-
RT   acetyltransferase (NAT2) alleles.";
RL   Drug Metab. Dispos. 22:371-376(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-24; GLN-64;
RP   THR-114; MET-193; GLN-197; HIS-208; ARG-268 AND GLU-286.
RX   PubMed=16416399; DOI=10.1086/500614;
RA   Patin E., Barreiro L.B., Sabeti P.C., Austerlitz F., Luca F.,
RA   Sajantila A., Behar D.M., Semino O., Sakuntabhai A., Guiso N.,
RA   Gicquel B., McElreavey K., Harding R.M., Heyer E., Quintana-Murci L.;
RT   "Deciphering the ancient and complex evolutionary history of human
RT   arylamine N-acetyltransferase genes.";
RL   Am. J. Hum. Genet. 78:423-436(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE NAT2*12A), AND VARIANT
RP   ARG-268.
RA   Doll M.A., Satran S.L., Hein D.W.;
RL   Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES NAT2*5D; NAT2*6D;
RP   NAT2*14G), AND VARIANTS GLN-64; THR-114; GLN-197 AND ARG-268.
RA   Leff M.A., Doll M.A., Feng Y., Fretland A.J., Hein D.W.;
RL   Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-114.
RA   Banerjee M., Anitha A.;
RT   "A novel linkage of two NAT2 mutations.";
RL   Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-114 AND ARG-268.
RA   Pillai A.A., Banerjee M.;
RT   "A novel allele showing linkage with 282, 341, 481, 803 point
RT   mutations in the NAT2 gene.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-114 AND ARG-268.
RA   Pillai A.A., Banerjee M.;
RT   "A novel NAT2 allele with point mutations 341, 481, 803, 859 in the
RT   ethnic populations of Kerala.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-114; ASN-122;
RP   PHE-137 AND ARG-268.
RA   Doll M.A., Zang Y., Yeager M., Welch R., Chanock S., Hein D.W.;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-24; GLN-64;
RP   THR-114; GLN-197; LEU-228; ARG-268 AND GLU-286.
RG   NIEHS SNPs program;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLN-197.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-22.
RX   PubMed=1676262; DOI=10.1016/0006-291X(91)90676-X;
RA   Ebisawa T., Deguchi T.;
RT   "Structure and restriction fragment length polymorphism of genes for
RT   human liver arylamine N-acetyltransferases.";
RL   Biochem. Biophys. Res. Commun. 177:1252-1257(1991).
RN   [18]
RP   PROTEIN SEQUENCE OF 18-33 AND 189-197.
RX   PubMed=2924904; DOI=10.1016/0014-5793(89)81193-7;
RA   Grant D.M., Lottspeich F., Meyer U.A.;
RT   "Evidence for two closely related isozymes of arylamine N-
RT   acetyltransferase in human liver.";
RL   FEBS Lett. 244:203-207(1989).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) IN COMPLEX WITH COENZYME A.
RX   PubMed=17656365; DOI=10.1074/jbc.M704138200;
RA   Wu H., Dombrovsky L., Tempel W., Martin F., Loppnau P.,
RA   Goodfellow G.H., Grant D.M., Plotnikov A.N.;
RT   "Structural basis of substrate-binding specificity of human arylamine
RT   N-acetyltransferases.";
RL   J. Biol. Chem. 282:30189-30197(2007).
RN   [20]
RP   VARIANTS.
RX   PubMed=2068113; DOI=10.1073/pnas.88.14.6333;
RA   Vatsis K.P., Martell K.J., Weber W.W.;
RT   "Diverse point mutations in the human gene for polymorphic N-
RT   acetyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:6333-6337(1991).
RN   [21]
RP   VARIANTS.
RX   PubMed=8466518; DOI=10.1006/bbrc.1993.1289;
RA   Abe M., Deguchi T., Suzuki T.;
RT   "The structure and characteristics of a fourth allele of polymorphic
RT   N-acetyltransferase gene found in the Japanese population.";
RL   Biochem. Biophys. Res. Commun. 191:811-816(1993).
RN   [22]
RP   VARIANTS NAT2*17 PRO-145 AND NAT2*18 THR-282.
RX   PubMed=7920692;
RA   Lin H.J., Han C.Y., Lin B.K., Hardy S.;
RT   "Ethnic distribution of slow acetylator mutations in the polymorphic
RT   N-acetyltransferase (NAT2) gene.";
RL   Pharmacogenetics 4:125-134(1994).
CC   -!- FUNCTION: Participates in the detoxification of a plethora of
CC       hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation
CC       of various arylamine and heterocyclic amine substrates and is able
CC       to bioactivate several known carcinogens.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + an arylamine = CoA + an N-
CC       acetylarylamine.
CC   -!- INTERACTION:
CC       Q13315:ATM; NbExp=2; IntAct=EBI-9057228, EBI-495465;
CC       Q06609:RAD51; NbExp=4; IntAct=EBI-9057228, EBI-297202;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- POLYMORPHISM: Polymorphisms in NAT2 are the cause of slow and fast
CC       acetylation phenotypes [MIM:243400] and influence drug therapy
CC       response and susceptibility to chemical toxicity or
CC       carcinogenicity. {ECO:0000269|PubMed:16416399}.
CC   -!- SIMILARITY: Belongs to the arylamine N-acetyltransferase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK51711.1; Type=Frameshift; Positions=287; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NAT2ID41498ch8p22.html";
CC   -!- WEB RESOURCE: Name=NAT; Note=NAT alleles;
CC       URL="http://nat.mbg.duth.gr/";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nat2/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=NAT2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X14672; CAA32802.1; -; Genomic_DNA.
DR   EMBL; D90040; BAA14094.1; -; mRNA.
DR   EMBL; D90042; BAA14096.1; -; mRNA.
DR   EMBL; D10870; BAA01640.1; -; Genomic_DNA.
DR   EMBL; D10871; BAA01641.1; -; Genomic_DNA.
DR   EMBL; D10872; BAA01642.1; -; Genomic_DNA.
DR   EMBL; U23052; AAA64584.1; -; Genomic_DNA.
DR   EMBL; U23434; AAA64585.1; -; Genomic_DNA.
DR   EMBL; DQ305496; ABC26032.1; -; Genomic_DNA.
DR   EMBL; DQ305497; ABC26033.1; -; Genomic_DNA.
DR   EMBL; DQ305498; ABC26034.1; -; Genomic_DNA.
DR   EMBL; DQ305499; ABC26035.1; -; Genomic_DNA.
DR   EMBL; DQ305500; ABC26036.1; -; Genomic_DNA.
DR   EMBL; DQ305501; ABC26037.1; -; Genomic_DNA.
DR   EMBL; DQ305502; ABC26038.1; -; Genomic_DNA.
DR   EMBL; DQ305503; ABC26039.1; -; Genomic_DNA.
DR   EMBL; DQ305504; ABC26040.1; -; Genomic_DNA.
DR   EMBL; DQ305505; ABC26041.1; -; Genomic_DNA.
DR   EMBL; DQ305506; ABC26042.1; -; Genomic_DNA.
DR   EMBL; DQ305507; ABC26043.1; -; Genomic_DNA.
DR   EMBL; DQ305508; ABC26044.1; -; Genomic_DNA.
DR   EMBL; DQ305509; ABC26045.1; -; Genomic_DNA.
DR   EMBL; DQ305510; ABC26046.1; -; Genomic_DNA.
DR   EMBL; DQ305511; ABC26047.1; -; Genomic_DNA.
DR   EMBL; DQ305512; ABC26048.1; -; Genomic_DNA.
DR   EMBL; DQ305513; ABC26049.1; -; Genomic_DNA.
DR   EMBL; DQ305514; ABC26050.1; -; Genomic_DNA.
DR   EMBL; DQ305515; ABC26051.1; -; Genomic_DNA.
DR   EMBL; DQ305516; ABC26052.1; -; Genomic_DNA.
DR   EMBL; DQ305517; ABC26053.1; -; Genomic_DNA.
DR   EMBL; DQ305518; ABC26054.1; -; Genomic_DNA.
DR   EMBL; DQ305519; ABC26055.1; -; Genomic_DNA.
DR   EMBL; DQ305520; ABC26056.1; -; Genomic_DNA.
DR   EMBL; DQ305521; ABC26057.1; -; Genomic_DNA.
DR   EMBL; DQ305522; ABC26058.1; -; Genomic_DNA.
DR   EMBL; DQ305523; ABC26059.1; -; Genomic_DNA.
DR   EMBL; DQ305524; ABC26060.1; -; Genomic_DNA.
DR   EMBL; DQ305525; ABC26061.1; -; Genomic_DNA.
DR   EMBL; DQ305526; ABC26062.1; -; Genomic_DNA.
DR   EMBL; DQ305527; ABC26063.1; -; Genomic_DNA.
DR   EMBL; DQ305528; ABC26064.1; -; Genomic_DNA.
DR   EMBL; DQ305529; ABC26065.1; -; Genomic_DNA.
DR   EMBL; DQ305530; ABC26066.1; -; Genomic_DNA.
DR   EMBL; DQ305531; ABC26067.1; -; Genomic_DNA.
DR   EMBL; DQ305532; ABC26068.1; -; Genomic_DNA.
DR   EMBL; DQ305533; ABC26069.1; -; Genomic_DNA.
DR   EMBL; DQ305534; ABC26070.1; -; Genomic_DNA.
DR   EMBL; DQ305535; ABC26071.1; -; Genomic_DNA.
DR   EMBL; DQ305536; ABC26072.1; -; Genomic_DNA.
DR   EMBL; DQ305537; ABC26073.1; -; Genomic_DNA.
DR   EMBL; DQ305538; ABC26074.1; -; Genomic_DNA.
DR   EMBL; DQ305539; ABC26075.1; -; Genomic_DNA.
DR   EMBL; DQ305540; ABC26076.1; -; Genomic_DNA.
DR   EMBL; DQ305541; ABC26077.1; -; Genomic_DNA.
DR   EMBL; DQ305542; ABC26078.1; -; Genomic_DNA.
DR   EMBL; DQ305543; ABC26079.1; -; Genomic_DNA.
DR   EMBL; DQ305544; ABC26080.1; -; Genomic_DNA.
DR   EMBL; DQ305545; ABC26081.1; -; Genomic_DNA.
DR   EMBL; DQ305546; ABC26082.1; -; Genomic_DNA.
DR   EMBL; DQ305547; ABC26083.1; -; Genomic_DNA.
DR   EMBL; DQ305548; ABC26084.1; -; Genomic_DNA.
DR   EMBL; DQ305549; ABC26085.1; -; Genomic_DNA.
DR   EMBL; DQ305550; ABC26086.1; -; Genomic_DNA.
DR   EMBL; DQ305551; ABC26087.1; -; Genomic_DNA.
DR   EMBL; DQ305552; ABC26088.1; -; Genomic_DNA.
DR   EMBL; DQ305553; ABC26089.1; -; Genomic_DNA.
DR   EMBL; DQ305554; ABC26090.1; -; Genomic_DNA.
DR   EMBL; DQ305555; ABC26091.1; -; Genomic_DNA.
DR   EMBL; DQ305556; ABC26092.1; -; Genomic_DNA.
DR   EMBL; DQ305557; ABC26093.1; -; Genomic_DNA.
DR   EMBL; DQ305558; ABC26094.1; -; Genomic_DNA.
DR   EMBL; DQ305559; ABC26095.1; -; Genomic_DNA.
DR   EMBL; DQ305560; ABC26096.1; -; Genomic_DNA.
DR   EMBL; DQ305561; ABC26097.1; -; Genomic_DNA.
DR   EMBL; DQ305562; ABC26098.1; -; Genomic_DNA.
DR   EMBL; DQ305563; ABC26099.1; -; Genomic_DNA.
DR   EMBL; DQ305564; ABC26100.1; -; Genomic_DNA.
DR   EMBL; DQ305565; ABC26101.1; -; Genomic_DNA.
DR   EMBL; DQ305566; ABC26102.1; -; Genomic_DNA.
DR   EMBL; DQ305567; ABC26103.1; -; Genomic_DNA.
DR   EMBL; DQ305568; ABC26104.1; -; Genomic_DNA.
DR   EMBL; DQ305569; ABC26105.1; -; Genomic_DNA.
DR   EMBL; DQ305570; ABC26106.1; -; Genomic_DNA.
DR   EMBL; DQ305571; ABC26107.1; -; Genomic_DNA.
DR   EMBL; DQ305572; ABC26108.1; -; Genomic_DNA.
DR   EMBL; DQ305573; ABC26109.1; -; Genomic_DNA.
DR   EMBL; DQ305574; ABC26110.1; -; Genomic_DNA.
DR   EMBL; DQ305575; ABC26111.1; -; Genomic_DNA.
DR   EMBL; DQ305576; ABC26112.1; -; Genomic_DNA.
DR   EMBL; DQ305577; ABC26113.1; -; Genomic_DNA.
DR   EMBL; DQ305578; ABC26114.1; -; Genomic_DNA.
DR   EMBL; DQ305579; ABC26115.1; -; Genomic_DNA.
DR   EMBL; DQ305580; ABC26116.1; -; Genomic_DNA.
DR   EMBL; DQ305581; ABC26117.1; -; Genomic_DNA.
DR   EMBL; DQ305582; ABC26118.1; -; Genomic_DNA.
DR   EMBL; DQ305583; ABC26119.1; -; Genomic_DNA.
DR   EMBL; DQ305584; ABC26120.1; -; Genomic_DNA.
DR   EMBL; DQ305585; ABC26121.1; -; Genomic_DNA.
DR   EMBL; DQ305586; ABC26122.1; -; Genomic_DNA.
DR   EMBL; DQ305587; ABC26123.1; -; Genomic_DNA.
DR   EMBL; DQ305588; ABC26124.1; -; Genomic_DNA.
DR   EMBL; DQ305589; ABC26125.1; -; Genomic_DNA.
DR   EMBL; DQ305590; ABC26126.1; -; Genomic_DNA.
DR   EMBL; DQ305591; ABC26127.1; -; Genomic_DNA.
DR   EMBL; DQ305592; ABC26128.1; -; Genomic_DNA.
DR   EMBL; DQ305593; ABC26129.1; -; Genomic_DNA.
DR   EMBL; DQ305594; ABC26130.1; -; Genomic_DNA.
DR   EMBL; DQ305595; ABC26131.1; -; Genomic_DNA.
DR   EMBL; DQ305596; ABC26132.1; -; Genomic_DNA.
DR   EMBL; DQ305597; ABC26133.1; -; Genomic_DNA.
DR   EMBL; DQ305598; ABC26134.1; -; Genomic_DNA.
DR   EMBL; DQ305599; ABC26135.1; -; Genomic_DNA.
DR   EMBL; DQ305600; ABC26136.1; -; Genomic_DNA.
DR   EMBL; DQ305601; ABC26137.1; -; Genomic_DNA.
DR   EMBL; DQ305602; ABC26138.1; -; Genomic_DNA.
DR   EMBL; DQ305603; ABC26139.1; -; Genomic_DNA.
DR   EMBL; DQ305604; ABC26140.1; -; Genomic_DNA.
DR   EMBL; DQ305605; ABC26141.1; -; Genomic_DNA.
DR   EMBL; DQ305606; ABC26142.1; -; Genomic_DNA.
DR   EMBL; DQ305607; ABC26143.1; -; Genomic_DNA.
DR   EMBL; DQ305608; ABC26144.1; -; Genomic_DNA.
DR   EMBL; DQ305609; ABC26145.1; -; Genomic_DNA.
DR   EMBL; DQ305610; ABC26146.1; -; Genomic_DNA.
DR   EMBL; DQ305611; ABC26147.1; -; Genomic_DNA.
DR   EMBL; DQ305612; ABC26148.1; -; Genomic_DNA.
DR   EMBL; DQ305613; ABC26149.1; -; Genomic_DNA.
DR   EMBL; DQ305614; ABC26150.1; -; Genomic_DNA.
DR   EMBL; DQ305615; ABC26151.1; -; Genomic_DNA.
DR   EMBL; DQ305616; ABC26152.1; -; Genomic_DNA.
DR   EMBL; DQ305617; ABC26153.1; -; Genomic_DNA.
DR   EMBL; DQ305618; ABC26154.1; -; Genomic_DNA.
DR   EMBL; DQ305619; ABC26155.1; -; Genomic_DNA.
DR   EMBL; DQ305620; ABC26156.1; -; Genomic_DNA.
DR   EMBL; DQ305621; ABC26157.1; -; Genomic_DNA.
DR   EMBL; DQ305622; ABC26158.1; -; Genomic_DNA.
DR   EMBL; DQ305623; ABC26159.1; -; Genomic_DNA.
DR   EMBL; DQ305624; ABC26160.1; -; Genomic_DNA.
DR   EMBL; DQ305625; ABC26161.1; -; Genomic_DNA.
DR   EMBL; DQ305626; ABC26162.1; -; Genomic_DNA.
DR   EMBL; DQ305627; ABC26163.1; -; Genomic_DNA.
DR   EMBL; DQ305628; ABC26164.1; -; Genomic_DNA.
DR   EMBL; DQ305629; ABC26165.1; -; Genomic_DNA.
DR   EMBL; DQ305630; ABC26166.1; -; Genomic_DNA.
DR   EMBL; DQ305631; ABC26167.1; -; Genomic_DNA.
DR   EMBL; DQ305632; ABC26168.1; -; Genomic_DNA.
DR   EMBL; DQ305633; ABC26169.1; -; Genomic_DNA.
DR   EMBL; DQ305634; ABC26170.1; -; Genomic_DNA.
DR   EMBL; DQ305635; ABC26171.1; -; Genomic_DNA.
DR   EMBL; DQ305636; ABC26172.1; -; Genomic_DNA.
DR   EMBL; DQ305637; ABC26173.1; -; Genomic_DNA.
DR   EMBL; DQ305638; ABC26174.1; -; Genomic_DNA.
DR   EMBL; DQ305639; ABC26175.1; -; Genomic_DNA.
DR   EMBL; DQ305640; ABC26176.1; -; Genomic_DNA.
DR   EMBL; DQ305641; ABC26177.1; -; Genomic_DNA.
DR   EMBL; DQ305642; ABC26178.1; -; Genomic_DNA.
DR   EMBL; DQ305643; ABC26179.1; -; Genomic_DNA.
DR   EMBL; DQ305644; ABC26180.1; -; Genomic_DNA.
DR   EMBL; DQ305645; ABC26181.1; -; Genomic_DNA.
DR   EMBL; DQ305646; ABC26182.1; -; Genomic_DNA.
DR   EMBL; DQ305647; ABC26183.1; -; Genomic_DNA.
DR   EMBL; DQ305648; ABC26184.1; -; Genomic_DNA.
DR   EMBL; DQ305649; ABC26185.1; -; Genomic_DNA.
DR   EMBL; DQ305650; ABC26186.1; -; Genomic_DNA.
DR   EMBL; DQ305651; ABC26187.1; -; Genomic_DNA.
DR   EMBL; DQ305652; ABC26188.1; -; Genomic_DNA.
DR   EMBL; DQ305653; ABC26189.1; -; Genomic_DNA.
DR   EMBL; DQ305654; ABC26190.1; -; Genomic_DNA.
DR   EMBL; DQ305655; ABC26191.1; -; Genomic_DNA.
DR   EMBL; U53473; AAA98976.1; -; Genomic_DNA.
DR   EMBL; AF042740; AAC03773.1; -; Genomic_DNA.
DR   EMBL; AF055874; AAC14117.1; -; Genomic_DNA.
DR   EMBL; AF055875; AAC14118.1; -; Genomic_DNA.
DR   EMBL; AF320309; AAG34181.1; -; Genomic_DNA.
DR   EMBL; AF348074; AAK51710.1; -; Genomic_DNA.
DR   EMBL; AF348075; AAK51711.1; ALT_FRAME; Genomic_DNA.
DR   EMBL; AY230251; AAO73561.1; -; Genomic_DNA.
DR   EMBL; AY230252; AAO73562.1; -; Genomic_DNA.
DR   EMBL; CR407631; CAG28559.1; -; mRNA.
DR   EMBL; AY331807; AAP81164.1; -; Genomic_DNA.
DR   EMBL; AC025062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC120051; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC015878; AAH15878.1; -; mRNA.
DR   EMBL; BC067218; AAH67218.1; -; mRNA.
DR   EMBL; M75163; AAA59906.1; -; Genomic_DNA.
DR   CCDS; CCDS6008.1; -.
DR   PIR; B34585; B34585.
DR   PIR; S02788; S02788.
DR   RefSeq; NP_000006.2; NM_000015.2.
DR   RefSeq; XP_016868427.1; XM_017012938.1.
DR   UniGene; Hs.2; -.
DR   PDB; 2PFR; X-ray; 1.92 A; A/B=2-290.
DR   PDBsum; 2PFR; -.
DR   ProteinModelPortal; P11245; -.
DR   SMR; P11245; -.
DR   BioGrid; 106528; 20.
DR   IntAct; P11245; 19.
DR   STRING; 9606.ENSP00000286479; -.
DR   ChEMBL; CHEMBL2194; -.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB04953; Ezogabine.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB01015; Sulfamethoxazole.
DR   iPTMnet; P11245; -.
DR   PhosphoSitePlus; P11245; -.
DR   BioMuta; NAT2; -.
DR   DMDM; 114238; -.
DR   MaxQB; P11245; -.
DR   PaxDb; P11245; -.
DR   PeptideAtlas; P11245; -.
DR   PRIDE; P11245; -.
DR   DNASU; 10; -.
DR   Ensembl; ENST00000286479; ENSP00000286479; ENSG00000156006.
DR   GeneID; 10; -.
DR   KEGG; hsa:10; -.
DR   UCSC; uc003wyw.2; human.
DR   CTD; 10; -.
DR   DisGeNET; 10; -.
DR   GeneCards; NAT2; -.
DR   HGNC; HGNC:7646; NAT2.
DR   HPA; HPA043704; -.
DR   MalaCards; NAT2; -.
DR   MIM; 243400; phenotype.
DR   MIM; 612182; gene.
DR   neXtProt; NX_P11245; -.
DR   Orphanet; 240887; Isoniazid toxicity.
DR   PharmGKB; PA18; -.
DR   eggNOG; ENOG410IFD6; Eukaryota.
DR   eggNOG; COG2162; LUCA.
DR   HOVERGEN; HBG000165; -.
DR   InParanoid; P11245; -.
DR   KO; K00622; -.
DR   OrthoDB; EOG091G0CO6; -.
DR   PhylomeDB; P11245; -.
DR   TreeFam; TF106311; -.
DR   BRENDA; 2.3.1.5; 2681.
DR   Reactome; R-HSA-156582; Acetylation.
DR   EvolutionaryTrace; P11245; -.
DR   GeneWiki; N-acetyltransferase_2; -.
DR   GenomeRNAi; 10; -.
DR   PRO; PR:P11245; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000156006; -.
DR   CleanEx; HS_NAT2; -.
DR   ExpressionAtlas; P11245; baseline and differential.
DR   Genevisible; P11245; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0004060; F:arylamine N-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0015179; F:L-amino acid transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001447; Arylamine_N-AcTrfase.
DR   PANTHER; PTHR11786; PTHR11786; 1.
DR   Pfam; PF00797; Acetyltransf_2; 1.
DR   PRINTS; PR01543; ANATRNSFRASE.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Polymorphism; Reference proteome;
KW   Transferase.
FT   CHAIN         1    290       Arylamine N-acetyltransferase 2.
FT                                /FTId=PRO_0000107905.
FT   REGION      106    107       Substrate binding. {ECO:0000305}.
FT   ACT_SITE     68     68       Acyl-thioester intermediate.
FT   ACT_SITE    107    107
FT   ACT_SITE    122    122
FT   BINDING     103    103       Coenzyme A.
FT                                {ECO:0000269|PubMed:17656365}.
FT   BINDING     104    104       Coenzyme A; via amide nitrogen.
FT                                {ECO:0000269|PubMed:17656365}.
FT   BINDING     208    208       Coenzyme A.
FT                                {ECO:0000269|PubMed:17656365}.
FT   BINDING     214    214       Coenzyme A.
FT                                {ECO:0000269|PubMed:17656365}.
FT   BINDING     287    287       Coenzyme A.
FT                                {ECO:0000269|PubMed:17656365}.
FT   VARIANT      24     24       L -> I (in dbSNP:rs45477599).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|Ref.14}.
FT                                /FTId=VAR_018853.
FT   VARIANT      64     64       R -> Q (in allele NAT2*14A, allele
FT                                NAT2*14B, allele NAT2*14C, allele
FT                                NAT2*14D, allele NAT2*14E, allele
FT                                NAT2*14F and allele NAT2*14G; a slow
FT                                acetylator; dbSNP:rs1801279).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:7915226,
FT                                ECO:0000269|Ref.14, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_004608.
FT   VARIANT      64     64       R -> W (in allele NAT2*19;
FT                                dbSNP:rs1805158).
FT                                /FTId=VAR_009075.
FT   VARIANT     114    114       I -> T (in allele NAT2*5A, allele
FT                                NAT2*5B, allele NAT2*5C, allele NAT2*5D,
FT                                allele NAT2*5E, allele NAT2*5F, allele
FT                                NAT2*14B and allele NAT2*14E; a slow
FT                                acetylator; dbSNP:rs1801280).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:7915226,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.14,
FT                                ECO:0000269|Ref.8, ECO:0000269|Ref.9}.
FT                                /FTId=VAR_004609.
FT   VARIANT     122    122       D -> N (in dbSNP:rs4986996).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_020385.
FT   VARIANT     135    135       L -> V (in dbSNP:rs12720065).
FT                                /FTId=VAR_046905.
FT   VARIANT     137    137       L -> F (in dbSNP:rs4986997).
FT                                {ECO:0000269|Ref.12}.
FT                                /FTId=VAR_020386.
FT   VARIANT     145    145       Q -> P (in allele NAT2*17).
FT                                {ECO:0000269|PubMed:7920692}.
FT                                /FTId=VAR_009076.
FT   VARIANT     193    193       T -> M. {ECO:0000269|PubMed:16416399}.
FT                                /FTId=VAR_028781.
FT   VARIANT     197    197       R -> Q (in allele NAT2*5E, allele
FT                                NAT2*6A, allele NAT2*6B, allele NAT2*6C,
FT                                allele NAT2*6D and allele NAT2*14D; a
FT                                slow acetylator; dbSNP:rs1799930).
FT                                {ECO:0000269|PubMed:1381364,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|Ref.14, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_004610.
FT   VARIANT     208    208       Y -> H (in dbSNP:rs56387565).
FT                                {ECO:0000269|PubMed:16416399}.
FT                                /FTId=VAR_028782.
FT   VARIANT     228    228       P -> L (in dbSNP:rs45518335).
FT                                {ECO:0000269|Ref.14}.
FT                                /FTId=VAR_018854.
FT   VARIANT     268    268       K -> R (in allele NAT2*5B, allele
FT                                NAT2*5C, allele NAT2*5F, allele NAT2*6C,
FT                                allele NAT2*12A, allele NAT2*14B, allele
FT                                NAT2*14C, allele NAT2*14E, allele
FT                                NAT2*14F and allele NAT2*14G;
FT                                dbSNP:rs1208).
FT                                {ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:7915226,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.14,
FT                                ECO:0000269|Ref.7, ECO:0000269|Ref.8}.
FT                                /FTId=VAR_004611.
FT   VARIANT     280    280       V -> M (in dbSNP:rs56393504).
FT                                /FTId=VAR_061368.
FT   VARIANT     282    282       K -> T (in allele NAT2*18;
FT                                dbSNP:rs56054745).
FT                                {ECO:0000269|PubMed:7920692}.
FT                                /FTId=VAR_009077.
FT   VARIANT     286    286       G -> E (in allele NAT2*7A and allele
FT                                NAT2*7B; a slow acetylator;
FT                                dbSNP:rs1799931).
FT                                {ECO:0000269|PubMed:1381364,
FT                                ECO:0000269|PubMed:16416399,
FT                                ECO:0000269|PubMed:1968463,
FT                                ECO:0000269|Ref.14}.
FT                                /FTId=VAR_004612.
FT   CONFLICT      6      6       Y -> D (in Ref. 13; CAG28559).
FT                                {ECO:0000305}.
FT   CONFLICT     30     30       H -> T (in Ref. 18; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    286    286       G -> R (in Ref. 9; AAG34181).
FT                                {ECO:0000305}.
FT   HELIX         2      9       {ECO:0000244|PDB:2PFR}.
FT   HELIX        21     34       {ECO:0000244|PDB:2PFR}.
FT   HELIX        40     43       {ECO:0000244|PDB:2PFR}.
FT   HELIX        52     59       {ECO:0000244|PDB:2PFR}.
FT   HELIX        68     82       {ECO:0000244|PDB:2PFR}.
FT   STRAND       85     95       {ECO:0000244|PDB:2PFR}.
FT   HELIX        96     98       {ECO:0000244|PDB:2PFR}.
FT   STRAND      107    114       {ECO:0000244|PDB:2PFR}.
FT   STRAND      117    121       {ECO:0000244|PDB:2PFR}.
FT   HELIX       127    129       {ECO:0000244|PDB:2PFR}.
FT   STRAND      142    144       {ECO:0000244|PDB:2PFR}.
FT   STRAND      149    155       {ECO:0000244|PDB:2PFR}.
FT   STRAND      158    164       {ECO:0000244|PDB:2PFR}.
FT   STRAND      167    171       {ECO:0000244|PDB:2PFR}.
FT   HELIX       173    175       {ECO:0000244|PDB:2PFR}.
FT   STRAND      185    192       {ECO:0000244|PDB:2PFR}.
FT   HELIX       199    202       {ECO:0000244|PDB:2PFR}.
FT   HELIX       203    211       {ECO:0000244|PDB:2PFR}.
FT   HELIX       216    219       {ECO:0000244|PDB:2PFR}.
FT   STRAND      222    226       {ECO:0000244|PDB:2PFR}.
FT   STRAND      228    235       {ECO:0000244|PDB:2PFR}.
FT   STRAND      238    247       {ECO:0000244|PDB:2PFR}.
FT   STRAND      250    257       {ECO:0000244|PDB:2PFR}.
FT   HELIX       260    269       {ECO:0000244|PDB:2PFR}.
FT   STRAND      285    288       {ECO:0000244|PDB:2PFR}.
SQ   SEQUENCE   290 AA;  33542 MW;  63EE3BC2107F12B9 CRC64;
     MDIEAYFERI GYKNSRNKLD LETLTDILEH QIRAVPFENL NMHCGQAMEL GLEAIFDHIV
     RRNRGGWCLQ VNQLLYWALT TIGFQTTMLG GYFYIPPVNK YSTGMVHLLL QVTIDGRNYI
     VDAGSGSSSQ MWQPLELISG KDQPQVPCIF CLTEERGIWY LDQIRREQYI TNKEFLNSHL
     LPKKKHQKIY LFTLEPRTIE DFESMNTYLQ TSPTSSFITT SFCSLQTPEG VYCLVGFILT
     YRKFNYKDNT DLVEFKTLTE EEVEEVLKNI FKISLGRNLV PKPGDGSLTI
//
